Synthetic Bone Graft Substitutes companies

  • Report ID: 2850
  • Published Date: Aug 29, 2025
  • Report Format: PDF, PPT

Key Synthetic Bone Graft Substitutes Market Players:

    There is a prominent visibility for the synthetic bone graft substitutes market due to the presence of key organizations with a collective aim of capturing a high market share. The market presents itself as a highly consolidated form, with Medtronic, Stryker, and Zimmer Biomet controlling 61% of global revenue. In this regard, NIH states that Stryker’s 3D-printed Tritanium grafts reduced revision rates by 30%. Similarly, in 2023, Zimmer Biomet acquired Embody, which strengthened its collagen graft portfolio, reflecting positive market adoption. Focus on affordable healthcare and collaborations with regulatory frameworks further strengthens the global market landscape.

    • Medtronic plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Stryker Corporation
    • Zimmer Biomet Holdings
    • Baxter International
    • Smith+Nephew
    • Johnson & Johnson
    • Olympus Corporation
    • NuVasive, Inc.
    • Wright Medical Group
    • Orthofix Medical
    • DJO Global (Enovis)
    • Cerapedics
    • Biocomposites Ltd
    • Graftys
    • Xtant Medical
    • Amedica Corporation
    • Surgival
    • Osseon LLC
    • Bioventus LLC
    • Osteopore International

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of synthetic bone graft substitutes is assessed at USD 1.42 billion.

Synthetic Bone Graft Substitutes Market size was over USD 1.33 billion in 2025 and is projected to reach USD 2.53 billion by 2035, witnessing around 6.8% CAGR during the forecast period i.e., between 2026-2035.

North America industry is set to account for largest revenue share of 48.5% by 2035, North America industry is likely to dominate majority revenue share of 48.5% by 2035.

The major players in the market are Baxter International, Inc., DePuy Synthes Companies, Wright Medical Group N.V., Medtronic, Arthrex, Inc., Kuros Biosciences, Zimmer Biomet, and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos